Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation

NCT00471133 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma (Skin)
Intraocular Melanoma

Interventions

BIOLOGICAL: Xenogeneic Tyrosinase DNA Vaccine
DEVICE: TriGrid Delivery System for Intramuscular Electroporation

Sponsor

Ichor Medical Systems Incorporated

Collaborators

[object Object]